Bioorganic and Medicinal Chemistry Letters p. 2467 - 2472 (1998)
Update date:2022-08-05
Topics:
Nerenberg, Jennie B.
Erb, Jill M.
Thompson, Wayne J.
Lee, Hee-Yoon
Guare, James P.
Munson, Peter M.
Bergman, Jeffrey M.
Huff, Joel R.
Broten, Theodore P.
Chang, Raymond S. L.
Chen, Tsing B.
O'Malley, Stacey
Schorn, Terry W.
Scott, Ann L.
Benign prostatic hyperplasia can be managed pharmacologically with α-1 adrenergic receptor antagonists. Agents that demonstrate selectivity for the α-la receptor subtype may offer advantages in clinical applications with respect to hypotensive side effect
View MoreChengdu Boon Stream Chemical Industry Co.,Ltd.
Contact:+86-28-83156758
Address:No.859,Dongzikou Road,Jinniu District,Chengdu,Sichuan,P.R.China
Shandong Xinhua Pharmaceutical Co.,Ltd
website:http://www.xhzy.com
Contact:+86-533-2196801
Address:1 lutai road,zhangdian dis,Zibo City
Kunming Biohome Technology Co. Ltd.
website:http://www.biohometech.com/
Contact:86-871-67428869
Address:kunming
Ningbo Tide Imp. & Exp. Co., Ltd.
Contact:+86-571-8993 7933; +86-571-8993 6453
Address:7/F Anno Domini Building, Tower South, 8 Qiu Shi Road,Hangzhou,China.
Xi'an Costrong Pharmaceutical Co., Ltd.
Contact:029- 68576496
Address:Room 2004,Shuibao Building,No.190,South Erhuan Rd, Yanta District,Xi'an,Shaan Xi,China
Doi:10.1021/jo01271a045
(1968)Doi:10.1039/DT9950001857
(1995)Doi:10.1248/cpb.15.1331
(1967)Doi:10.1039/j39670002700
(1967)Doi:10.1016/S0040-4039(00)72432-4
(1973)Doi:10.1016/0957-4166(95)00201-Y
(1995)
